Randomized trials to optimize treatment of multidrug-resistant tuberculosis.
Mitnick
Carole D
CD
Harvard Medical School, Boston, Massachusetts, United States of America. carole_mitnick@hms.harvard.edu
Castro
Kenneth G
KG
Harrington
Mark
M
Sacks
Leonard V
LV
Burman
William
W
D000995:Antitubercular Agents / Q000627:therapeutic use*; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy* / Q000382:microbiology; D024841:Fluoroquinolones / Q000627:therapeutic use; D006801:Humans; D009169:Mycobacterium tuberculosis; D016032:Randomized Controlled Trials as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D024841:Fluoroquinolones